Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomised, double blind, multicentre study. European Multicentre Study Group for Cabergoline in Lactation Inhibition.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (18)
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
1959 • 14,850 citations
Simultaneous Statistical Inference
1981 • 5,665 citations
“Proving the null hypothesis” in clinical trials
1982 • 870 citations
1995 Physicians' Desk Reference
1995 • 565 citations
Significance Testing to Establish Equivalence between Treatments, with Special Reference to Data in the Form of 2 x 2 Tables
1977 • 400 citations
Increased Risk of Suicide in Persons With AIDS
1988 • 390 citations
PUERPERAL THROMBOEMBOLISM AND SUPPRESSION OF LACTATION
1967 • 165 citations
Long-Lasting Prolactin-Lowering Effect of Cabergoline, A New Dopamine Agonist, in Hyperprolactinemic Patients
1986 • 126 citations
LACTATION SUPPRESSION
1980 • 37 citations
Prevention of puerperal lactation by a single oral administration of the new prolactin-inhibiting drug, cabergoline.
1988 • 24 citations
FACTORS INFLUENCING PUERPERAL THROMBO‐EMBOLISM
1968 • 21 citations
Suppression of puerperal lactation by metergoline.
1978 • 17 citations
Inhibition of lactation by a long-acting bromocriptine.
1986 • 17 citations
Bromocriptine mesylate for prevention of postpartum lactation.
1981 • 17 citations
Use of Bromocriptine in the Inhibition of Puerperal Lactation
1979 • 16 citations
Lactation-inhibiting and prolactin-lowering effect of lisuride and bromocriptine: A comparative study
1981 • 12 citations
Inhibition of Lactation with Depot‐Bromocriptine
1986 • 12 citations
Suppression of lactation
1986 • 2 citations